A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression.

@article{Lozano2012AMP,
  title={A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression.},
  author={Andres M. Lozano and Peter Giacobbe and Clement Hamani and Sakina J. Rizvi and Sidney H. Kennedy and Theodore T. Kolivakis and Guy Debonnel and Abbas F. Sadikot and Raymond W. Lam and Andrew K. Howard and Magdalena Ilcewicz-Klimek and Christopher R. Honey and Helen S. Mayberg},
  journal={Journal of neurosurgery},
  year={2012},
  volume={116 2},
  pages={
          315-22
        }
}
OBJECT Deep brain stimulation (DBS) has been recently investigated as a treatment for major depression. One of the proposed targets for this application is the subcallosal cingulate gyrus (SCG). To date, promising results after SCG DBS have been reported by a single center. In the present study the authors investigated whether these findings may be replicated at different institutions. They conducted a 3-center prospective open-label trial of SCG DBS for 12 months in patients with treatment… Expand
Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study.
TLDR
Longer pulse width stimulation may have a role in stimulus optimization for SCC-DBS in TRD, suggesting that the authors do not yet know the optimal target or stimulus parameters for this therapy. Expand
Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.
TLDR
This study confirmed the safety and feasibility of subcallosal cingulate DBS as a treatment for treatment-resistant depression but did not show statistically significant antidepressant efficacy in a 6-month double-blind, sham-controlled trial. Expand
Deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: A double-blinded randomized controlled study and long-term follow-up in eight patients.
TLDR
Long-term improvement after SCG-DBS revealed a stable effect and longitudinal investigations of large samples are needed to investigate long-term effects of DBS for TRD. Expand
Metabolic activity in subcallosal cingulate predicts response to deep brain stimulation for depression
TLDR
Reduction in SCC CMRGlu 6 months post DBS correlated with symptom improvement and is the first evidence of an image-based treatment selection biomarker that predicts SCC DBS response. Expand
Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial
TLDR
Important aspects for the planning of RCTs in the field of DBS for severe and chronic diseases are discussed including meaningful phases of intra-individual and between-group comparisons and timeline instead of single endpoint analyses. Expand
One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression.
TLDR
The results of this study suggest that long term high frequency stimulation might confer the best results in patients with TR-MDD. Expand
Subcallosal Cingulate Cortex Deep Brain Stimulation for the Treatment of Refractory Mood Disorders: Evidence and Challenges
TLDR
The data from these open-label studies suggest that SCC DBS is associated with robust and sustained antidepressant responses and improved quality of life in patients with TRD and bipolar depression. Expand
A Decade of Progress in Deep Brain Stimulation of the Subcallosal Cingulate for the Treatment of Depression
TLDR
A comprehensive overview of the progress of DBS of the subcallosal cingulate in humans and the medial prefrontal cortex, its rodent homolog, for preclinical animal studies is provided and the various antidepressant-like behaviors induced by medial cortex DBS are discussed. Expand
A systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression
TLDR
DBS significantly alleviates depressive symptoms in TRD patients by targeting the SCG, VC/VS, MFB, and NAcc and was effective, with high response rates at 1, 3, 6, and 12 months. Expand
Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression
TLDR
Results confirm that stimulation of the SCG is capable of exerting moderate acute and chronic antidepressant effects and the predictive value of these findings needs to be addressed in future studies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
TLDR
This study suggests that DBS is relatively safe and provides significant improvement in patients with TRD and likely acts by modulating brain networks whose dysfunction leads to depression. Expand
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years.
TLDR
Deep brain stimulation remains a safe and effective treatment for treatment-resistant depression and functional impairment in the areas of physical health and social functioning progressively improved up to the last follow-up visit. Expand
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
TLDR
Deep brain stimulation of the VC/VS offers promise for the treatment of refractory major depression. Expand
Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting.
TLDR
Based on the location of the active contacts used for long-term stimulation in responders, the authors suggest a standardized method of targeting the SCG in patients with MDD. Expand
Deep Brain Stimulation for Treatment-Resistant Depression
TLDR
It is suggested that disrupting focal pathological activity in limbic-cortical circuits using electrical stimulation of the subgenual cingulate white matter can effectively reverse symptoms in otherwise treatment-resistant depression. Expand
Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression
BACKGROUND While most patients with depression respond to combinations of pharmacotherapy, psychotherapy, and electroconvulsive therapy (ECT), there are patients requiring other treatments. DeepExpand
Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients
TLDR
Brain SPECT can provide information about mechanisms of action of rTMS and may have predictive value for the antidepressant efficacy of r TMS, and the rCBF in limbic structures was negatively correlated with the outcome and r CBF in several neocortical areas was positively correlated. Expand
Limbic–frontal circuitry in major depression: a path modeling metanalysis
TLDR
The creation of such models is a first step toward full characterization of the depression phenotype at the neural systems level, with implications for the future development of brain-based algorithms to determine optimal treatment selection for individual patients. Expand
The Subcallosal Cingulate Gyrus in the Context of Major Depression
TLDR
The anatomic and histologic attributes of the SCG and the morphologic and imaging changes observed in depression are reviewed and particular attention is given to the regional and downstream structures that could be influenced by the application of deep brain stimulation in this region. Expand
The functional neuroanatomy of the placebo effect.
TLDR
The common pattern of cortical glucose metabolism increases and limbic-paralimbic metabolism decreases in placebo and fluoxetine responders suggests that facilitation of these changes may be necessary for depression remission, regardless of treatment modality. Expand
...
1
2
3
4
...